Navigation Links
U.S. Hospital Sales Opportunities Maximized Through Functional Optimization
Date:8/15/2008

CHAPEL HILL, N.C., Aug. 15 /PRNewswire/ -- The U.S. hospital marketplace is multifaceted and can be divided into multiple market segments. In this challenging marketplace, pharmaceutical and biotechnology sales people must negotiate increasingly complex organizational and decision-making structures to effectively represent their brands. Hospital formulary decisions are not only being influenced by medical professionals focused on efficacy and safety but also by administrative personnel focused on operational efficiency and cost. Impactful benchmark research originally conducted by Best Practices, LLC in 2006 focused on understanding the variables in developing an effective sales force to service the hospital marketplace has been updated and published with comparisons drawn between current and historical data as appropriate.

In a benchmarking study that included such influential companies as Abbott, Astra Zeneca, Bayer, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, Procter & Gamble, Sanofi-Aventis, Schering-Plough, and Wyeth, key benchmark metrics and executive insights provide a basis for informing decision-making around critical structure, resource and process planning and execution.

For a complimentary summary of the full report "Sales Force Effectiveness: Benchmarking the Resources and Structure Required to Service the U.S. Hospital Marketplace," click on the following link http://www3.best-in-class.com/rr970.htm .

Key topic areas in the research include:

-- Targeting Key Decision Makers and Influencers

-- Hospital Sales Force Alignment, Structure and Support

-- Hospital Sales Force Training

-- GPO Focus

-- Lessons Learned

For more information on this report, contact Robert Naylor at rnaylor@best-in-class.com or (919) 767-9244. To access the full report or download a complimentary copy of the report summary, go to http://www3.best-in-class.com/rr958.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more than 15 years, our highly credentialed research staff has conducted primary research exclusively for our Fortune 500 client base.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
2. Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System
3. Florida Childrens Hospital and Disney Unite to Create Magical Pediatric Hospital
4. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
5. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
6. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
7. Candid Details on Hospitals Quality of Care Are Now at Your Fingertips - Just Like It Should Be
8. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
9. Chambersburg Hospital Streamlines Pharmacy Process and Increases Patient Safety With Omnicell WorkflowRx 5.0
10. American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest
11. Hospitals Adopt STERIS Advanced Room Sterilization Technology in the Fight Against Superbugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... This report analyzes the worldwide markets for Biostimulants ... Amino, & Fulvic), Extract Based, and Others. The report also ... & Turf, Row Crops, and Others. The report provides separate ... Japan , Europe , ... , and Rest of World. Annual estimates and forecasts are ...
(Date:12/8/2016)... 8, 2016  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... intratumoral cancer immunotherapies, today announced financial results for ... "We are delivering on our commitment to address ... IL-12. We are pleased with the early clinical ... and we are focused on advancing our lead ...
(Date:12/8/2016)... PUNE, India , December 8, 2016 ... is a comprehensive analysis, titled Global Amyloglucosidase Industry 2016 Market ... definition, classification, application, and industry chain overview are all covered ... project SWOT analysis, and investment return analysis of the Amyloglucosidase ... , , ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire-USNewswire/ ... treatments for congestive heart failure and type 2 ... license for a novel adeno-associated virus (AAV) vector ... Kay , M.D., Ph.D., at Stanford University. The ... of its paracrine gene therapy product pipeline. ...
Breaking Biology Technology:
(Date:11/22/2016)... , November 22, 2016 According to the new ... Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function ... by MarketsandMarkets, the market is expected to grow from USD 10.74 Billion ... of 16.79% between 2016 and 2022. Continue ... ...
(Date:11/17/2016)... -- AIC announces that it has just released a new white paper authored by Zettar ... high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be ...
(Date:11/14/2016)... , Nov. 14, 2016  Based on ... market, Frost & Sullivan recognizes FST Biometrics ... Award for Visionary Innovation Leadership. FST Biometrics ... biometric identification market by pioneering In Motion ... for instant, seamless, and non-invasive verification. This ...
Breaking Biology News(10 mins):